Literature Citations
1. Antimycobacterial Effects of Everolimus in a Human Granuloma Model. Ashley, D., J. Hernandez, R. Cao, K. To, A. Yegiazaryan, R. Abrahem, T. Nguyen, J. Owens, M. Lambros, S. Subbian, and V. Venketaraman. Journal of Clinical Medicine, 2020. 9(7): 2043. PMID[32610643]. PMCID[PMC7409120].
[PubMed]. TB_08_2020.
2. Synthesis of Isoniazid-1,2,3-triazole Conjugates: Antitubercular, Antimicrobial Evaluation and Molecular Docking Study. Badar, A.D., S.M. Sulakhe, M.B. Muluk, N. Rehman, P.P. Dixit, P.B. Choudhari, E.M. Rekha, D. Sriram, and K.P. Haval. Journal of Heterocyclic Chemistry. 19(14): p. 1178-1194. ISI[:000555563900001].
[WOS]. TB_08_2020.
3. Synthesis, Docking Study and Biological Evaluation of ᴅ-Fructofuranosyl and ᴅ-Tagatofuranosyl Sulfones as Potential Inhibitors of the Mycobacterial Galactan Synthesis Targeting the Galactofuranosyltransferase GlfT2. Baráth, M., J. Jakubčinová, Z. Konyariková, S. Kozmon, K. Mikušová, and M. Bella. Beilstein Journal of Organic Chemistry, 2020. 16: p. 1853-1862. PMID[32802202]. PMCID[PMC7404141].
[PubMed]. TB_08_2020.
4. Synthesis of Novel Sulfamethaoxazole 4-thiazolidinone Hybrids and Their Biological Evaluation. Bhat, M.A., M.A. Al-Omar, A.M. Naglah, and A.A. Khan. Molecules, 2020. 25(16): e3570. PMID[32781534]. PMCID[PMC7464187].
[PubMed]. TB_08_2020.
5. Synthesis, Characterization, Antimicrobial, Anti-tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(Pyridin-3-yl)-1H-benzo[D]imidazole and 1,3,4-Oxadiazole Analogy. Bhati, S., V. Kumar, S. Singh, and J. Singh. Letters in Drug Design & Discovery, 2020. 17(8): p. 1047-1059. ISI[:000556420300007].
[WOS]. TB_08_2020.
6. Synthetic-bioinformatic Natural Product Antibiotics with Diverse Modes of Action. Chu, J., B. Koirala, N. Forelli, X. Vila-Farres, M.A. Ternei, T. Ali, D.A. Colosimo, and S.F. Brady. Journal of the American Chemical Society, 2020. 142(33): p. 14158-14168. PMID[32697091].
[PubMed]. TB_08_2020.
7. Diterpenoids Isolated from the Samoan Marine Sponge Chelonaplysilla Sp. Inhibit Mycobacterium tuberculosis Growth. de Oliveira, J.A.M., D.E. Williams, S. Bonnett, J. Johnson, T. Parish, and R.J. Andersen. Journal of Antibiotics, 2020. 73(8): p. 568-573. PMID[32404991].
[PubMed]. TB_08_2020.
8. Antimycobacterial Activity of Laurinterol and Aplysin from Laurencia johnstonii. García-Davis, S., K. Leal-López, C.A. Molina-Torres, L. Vera-Cabrera, A.R. Díaz-Marrero, J.J. Fernández, P. Carranza-Rosales, and E. Viveros-Valdez. Marine Drugs, 2020. 18(6): 287. PMID[32486286]. PMCID[PMC7345040].
[PubMed]. TB_08_2020.
9. Potential Implications of the Use of Rapanea lelanophloeos (L.) Mez against Mycobacteria. Gibango, L., C.B. Oosthuizen, and N. Lall. South African Journal of Botany, 2020. 132: p. 388-394. ISI[:000554672800006].
[WOS]. TB_08_2020.
10. Ertapenem and Faropenem against Mycobacterium tuberculosis: In Vitro Testing and Comparison by Macro and Microdilution. Gonzalo, X., G. Satta, J. Ortiz Canseco, T.D. McHugh, and F. Drobniewski. BMC Microbiology, 2020. 20(1): 271. PMID[32867678]. PMCID[PMC7457350].
[PubMed]. TB_08_2020.
11. Discovery of a Novel Mycobacterial F-ATP Synthase Inhibitor and Its Potency in Combination with Diarylquinolines. Hotra, A., P. Ragunathan, P.S. Ng, P. Seankongsuk, A. Harikishore, J.P. Sarathy, W.G. Saw, U. Lakshmanan, P. Sae-Lao, N.P. Kalia, J. Shin, R. Kalyanasundaram, S. Anbarasu, K. Parthasarathy, C.N. Pradeep, H. Makhija, P. Dröge, A. Poulsen, J.H.L. Tan, K. Pethe, T. Dick, R.W. Bates, and G. Grüber. Angewandte Chemie, 2020. 59(32): p. 13295-13304. PMID[32337801].
[PubMed]. TB_08_2020.
12. In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl ether triclosan Analogues as Potential InhA Reductase Inhibitors. Ibrahim, T.S., E.S. Taher, E. Samir, M.M. A, A.N. Khayyat, M.F.A. Mohamed, R.M. Bokhtia, M.A. AlAwadh, I.A. Seliem, H.Z. Asfour, N.A. Alhakamy, S.S. Panda, and A.M.M. Al-Mahmoudy. Molecules, 2020. 25(14): e3125. PMID[32650556]. PMCID[PMC7397076].
[PubMed]. TB_08_2020.
13. In Silico Discovery and Biological Validation of Ligands of FAD Synthase, a Promising New Antimicrobial Target. Lans, I., E. Anoz-Carbonell, K. Palacio-Rodríguez, J.A. Aínsa, M. Medina, and P. Cossio. Plos Computational Biology, 2020. 16(8): e1007898. PMID[32797038]. PMCID[PMC7449411].
[PubMed]. TB_08_2020.
14. Structure-based Identification of Natural Compound Inhibitor against M. tuberculosis Thioredoxin reductase: Insight from Molecular Docking and Dynamics Simulation. Lata, S. and M. Akif. Journal of Biomolecular Structure and Dynamics, 2020: p. 1-10. PMID[32567497].
[PubMed]. TB_08_2020.
15. Antitubercular Polyhalogenated Phenothiazines and Phenoselenazine with Reduced Binding to CNS Receptors. Nizi, M.G., J. Desantis, Y. Nakatani, S. Massari, M.A. Mazzarella, G. Shetye, S. Sabatini, M.L. Barreca, G. Manfroni, T. Felicetti, R. Rushton-Green, K. Hards, G. Latacz, G. Satała, A.J. Bojarski, V. Cecchetti, M.H. Kolář, J. Handzlik, G.M. Cook, S.G. Franzblau, and O. Tabarrini. European Journal of Medicinal Chemistry, 2020. 201: 112420. PMID[32526553].
[PubMed]. TB_08_2020.
16. Design, Synthesis, in Silico Studies, and Evaluation of Novel Chalcones and Their Pyrazoline Derivatives for Antibacterial and Antitubercular Activities. Pola, S., K.K. Banoth, M. Sankaranarayanan, R. Ummani, and A. Garlapati. Medicinal Chemistry Research. 107: p. 133-152. ISI[000549810800002].
[WOS]. TB_08_2020.
17. Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis. Quigley, J., A. Peoples, A. Sarybaeva, D. Hughes, M. Ghiglieri, C. Achorn, A. Desrosiers, C. Felix, L. Liang, S. Malveira, W. Millett, A. Nitti, B. Tran, A. Zullo, C. Anklin, A. Spoering, L.L. Ling, and K. Lewis. mBio, 2020. 11(4): e01516-01520. PMID[32753498]. PMCID[PMC7407088].
[PubMed]. TB_08_2020.
18. Synthesis, Spectroscopic, in-Vitro and Computational Analysis of Hydrazones as Potential Antituberculosis Agents: (Part-I). Thorat, B.R., D. Rani, R.S. Yamgar, and S.N. Mali. Combinatorial Chemistry and High Throughput Screening, 2020. 23(5): p. 392-401. PMID[32209038].
[PubMed]. TB_08_2020.
19. Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus against Mycobacteria. Tran, H.T., J. Solnier, E.M. Pferschy-Wenzig, O. Kunert, L. Martin, S. Bhakta, L. Huynh, T.M. Le, R. Bauer, and F. Bucar. Antibiotics, 2020. 9(7): 390. PMID[32650510]. PMCID[PMC7400215].
[PubMed]. TB_08_2020.
20. Anti-tubercular Properties of 4-Amino-5-(4-fluoro-3- phenoxyphenyl)-4H-1,2,4-triazole-3-thiol and Its Schiff Bases: Computational Input and Molecular Dynamics. Venugopala, K.N., M. Kandeel, M. Pillay, P.K. Deb, H.H. Abdallah, M.F. Mahomoodally, and D. Chopra. Antibiotics, 2020. 9(9): e559. PMID[32878018].
[PubMed]. TB_08_2020.
21. Designing Novel Inhibitors against Cyclopropane Mycolic acid Synthase 3 (PcaA): Targeting Dormant State of Mycobacterium tuberculosis. Verma, J. and N. Subbarao. Journal of Biomolecular Structure and Dynamics, 2020: p. 1-16. PMID[32715934].
[PubMed]. TB_08_2020.
22. Synthesis, Characterization, and Biologic Activity of New Acyl hydrazides and 1,3,4-Oxadiazole Derivatives. Zarafu, I., L. Matei, C. Bleotu, P. Ionita, A. Tatibouët, A. Păun, I. Nicolau, A. Hanganu, C. Limban, D.C. Nuta, R.M. Nemeș, C.C. Diaconu, and C. Radulescu. Molecules, 2020. 25(14): e3308. PMID[32708236]. PMCID[PMC7396991].
[PubMed]. TB_08_2020.
23. Second-generation Meridianin Analogues Inhibit the Formation Of Mycobacterium smegmatis biofilms and Sensitize Polymyxin-resistant Gram-negative Bacteria to Colistin. Zeiler, M.J., R.J. Melander, and C. Melander. ChemMedChem. PMID[32662926].
[WOS]. TB_08_2020.
24. Design, Synthesis, and Biological Evaluation of Novel Thiazolidinone-containing Quinoxaline-1,4-di-N-oxides as Antimycobacterial and Antifungal Agents. Zhang, H., J. Zhang, W. Qu, S. Xie, L. Huang, D. Chen, Y. Tao, Z. Liu, Y. Pan, and Z. Yuan. Frontiers in Chemistry, 2020. 8: p. 598. PMID[32850634]. PMCID[PMC7424068].
[PubMed]. TB_08_2020.
Patent Citations
This month, no relevant Mycobacterium patents were identified.